Previous Article | Next Article ![]()
Applied and Environmental Microbiology, March 2009, p. 1778-1781, Vol. 75, No. 6
0099-2240/09/$08.00+0 doi:10.1128/AEM.00859-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
,
Xiangzhao Mao,1,
,¶
Yaling Shen,1
Yongjun Zhou,2
Jialiang Li,2
Lianrong Wang,2
Xinyi Tao,1
Liang Yang,1
Yuxiao Wang,1
Xiufen Zhou,2
Zixin Deng,2* and
Dongzhi Wei1*
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China,1 Laboratory of Microbial Metabolism and School of Life Science & Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China2
Received 15 April 2008/ Accepted 6 January 2009
Tailoring steps are often important for the activity of mature antibiotics. Here, we report that novel decarboxylated FR-008/candicidin derivatives were obtained from the P450 monooxygenase gene fscP mutant of Streptomyces sp. strain FR-008. The toxicity of decarboxylated FR-008/candicidin derivatives has been shown to be greatly reduced compared to that of wild-type FR-008/candicidin.
Published ahead of print on 9 January 2009.
Supplemental material for this article may be found at http://aem.asm.org/.
S.C. and X.M. are co-first authors and contributed equally to this work.
Present address: Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
¶ Present address: Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266071, People's Republic of China.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»